Categories AlphaGraphs, Earnings, Health Care

Infographic: How Thermo Fisher (TMO) performed in Q3 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) reported its third quarter 2025 earnings results today.

Revenue grew 5% year-over-year to $11.12 billion. Organic revenue growth was 3%.

Net income attributable to Thermo Fisher Scientific Inc. was $1.61 billion, or $4.27 per share, compared to $1.63 billion, or $4.25 per share, last year. Adjusted EPS grew 10% to $5.79.

“Our team did an outstanding job and delivered excellent operational performance in the quarter, reflecting the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. I’m also very pleased with the progress we made executing our strategy – launching outstanding new products, completing complementary acquisitions, and collaborating with OpenAI to accelerate scientific advancement.”Marc N. Casper, CEO

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Key metrics from Kroger’s (KR) Q3 2025 earnings results

The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical

Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights

Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or

HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results

Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top